Stay updated on Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial
Sign up to get notified when there's something new on the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page.

Latest updates to the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page
- CheckyesterdayChange DetectedPublication added: Integrated Safety Analysis of Filgotinib in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis Over a Treatment Duration of up to 5 Years, Mod Rheumatol, 2026.SummaryDifference0.0%

- Check8 days agoChange DetectedDifference0.1%

- Check15 days agoChange DetectedAdded Gurgaon, India, 122001 and removed Gūrgaon, India, 122001 from the locations list.SummaryDifference0.0%

- Check23 days agoChange DetectedAdded Rheumatoid arthritis as a related topic and MedlinePlus Genetics reference. Updated location to Gūrgaon, India, 122001 and revised page to v3.4.3.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded Gurgaon, India, 122001 as a trial location. Deleted references to Rheumatoid arthritis and related topics (MedlinePlus Genetics) and the diacritic variant of Gurgaon.SummaryDifference0.1%

- Check37 days agoChange DetectedAdded Rheumatoid arthritis as a topic and included a MedlinePlus Genetics related topics link to the page.SummaryDifference0.0%

Stay in the know with updates to Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page.